Joel Ernst

Joel Ernst is a Professor and Chief of Experimental Medicine at the University of California, San Francisco (UCSF). His research focuses on immunity to tuberculosis (TB), particularly mechanisms of immune evasion and vaccine development. His lab investigates human and mouse models to understand T cell antigen conservation and diversification in M. tuberculosis, with global collaborations. He leads the UCSF Center for Tuberculosis Leadership and contributes to initiatives like the UC TRAC Core Management Committee.

Research Interests: Dr. Ernst’s work spans TB vaccine design, host-pathogen interactions, and immune response characterization. His lab identifies protective T cell antigens and studies rare, diversifying TB antigens linked to superior immunity. Collaborations span multiple continents, emphasizing translational research to improve diagnostics and treatments.

Publications Trends: His articles focus on TB biomarkers (e.g., metabolic signatures, proteomics), immune cell dynamics (monocytes, Th17 cells), and molecular mechanisms (e.g., virulence factors like Tax1bp1). Work bridges basic science and clinical applications, such as HIV/TB co-infection and diagnostic advancements.

Grants & Advising: While specific grants aren’t detailed here, his lab’s extensive collaborative projects suggest significant funding in TB research. Advising details aren’t explicitly listed in the provided text.

Labs & Teams: Leads the Ernst Lab at UCSF’s Experimental Medicine and contributes to the UCSF Center for Tuberculosis Leadership, fostering interdisciplinary TB research.